The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Relapsing Remitting Multiple Sclerosis

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Shepherd Center, Atlanta, Georgia, United States
Contact: Study coordinator (Michelle Tidwell) · Michelle.Tidwell@shepherd.org · 404-367-1317
Contact: Study coordinator (Cathy Furbish) · Cathy.Furbish@shepherd.org · 404-350-7591
Contact: Principal Investigator (Jacqueline Rosenthal, MD)
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
Contact: Study coordinator (Adam Didouchevski) · adidouc1@jh.edu · 443-818-1451
Contact: Principal Investigator (Bardia Nourbakhsh, MD)
Minnesota Center for Multiple Sclerosis, Plymouth, Minnesota, United States
Contact: Study coordinator (Halie Kaufman) · HKaufman@vivoinfusion.com · 763-243-8180
Contact: Principal Investigator (Jonathan Calkwood, MD)
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Contact: Study coordinator (Tanya Khan) · Tanya.S.Khan@uth.tmc.edu · 713-704-0823
Contact: Principal Investigator (John Lincoln, MD)
UW Medicine Multiple Sclerosis Center-Northwest, Seattle, Washington, United States
Contact: Study coordinator (Elisa McGee) · emcgee@uw.edu · 206-598-9260
Contact: Principal Investigator (Yujie Wang, MD)
West Virginia University, Morgantown, West Virginia, United States
Contact: Study coordinator (Lauren Chase) · lauren.chase@wvumedicine.org · 304-598-4000
Contact: Principal Investigator (Melanie Ward, MD)